MedPath

Effect of a New Infant Cereal on Weight Gain

Not Applicable
Completed
Conditions
Infant Development
Interventions
Dietary Supplement: Standard Infant Cereal
Dietary Supplement: New Infant Cereal
Registration Number
NCT02165956
Lead Sponsor
Laboratorios Ordesa
Brief Summary

The purpose of this study is to determine whether a new infant cereal has an effect on weight gain and intestinal microbiota compared to a standard cereal in healthy infants .

Detailed Description

This is a multicenter, controlled, randomized, prospective, parallel-group, double-blind study to evaluate the effect of a new infant cereal supplemented with prebiotics, probiotics, vegetable proteins and a special blend of starches on weight gain and intestinal microbiota in healthy infants from 6 to 12 moths of age. Patients will be randomized to receive either the new infant cereal or a standard cereal.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
195
Inclusion Criteria
  • Lactating babies
  • 6 months of age
  • Informed consent signed by parents
Exclusion Criteria
  • Malformations, diseases or conditions that may alter development and/or nutritional status
  • Born very and extremely preterm (<32 weeks of gestational age)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard Infant CerealStandard Infant CerealThe amount of cereal administered will be free and from 6 to 12 months of age.
New Infant CerealNew Infant CerealThe amount of cereal administered will be free and from 6 to 12 months of age.
Primary Outcome Measures
NameTimeMethod
Changes in nutritional statusAt 6, 9, 12, 15 and 18 months of age

Difference between groups measured by a composite of nutritional parameters(weight, height, perimeters and skin fold measurements).

Secondary Outcome Measures
NameTimeMethod
Changes in intestinal microbiotaAt 6, 9, 12 and 18 months of age

Differences between groups measured by the analysis of faecal samples.

Changes in appetiteAt 6, 9, 12, 15 and 18 months of age

Differences between groups measured by a 3-day food record.

Tolerability of study productAt 6, 9, 12, 15 and 18 months of age

Differences between groups measured by frequency and type of a composite of gastrointestinal symptoms (regurgitation, irritability, flatulence and crying).

Trial Locations

Locations (5)

Centro de Salud Santo Grial

🇪🇸

Huesca, Spain

Consultorio de Soto de la Marina

🇪🇸

Soto de la marina, Santander, Spain

Centro de Salud Isabel II-Centro

🇪🇸

Santander, Spain

Centro de Salud Perpetuo Socorro

🇪🇸

Huesca, Spain

Centro de Salud El Alisal

🇪🇸

Santander, Spain

© Copyright 2025. All Rights Reserved by MedPath